In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug

References

• Abdelrahim ME, Chrystyn H. (2009). Aerodynamic characteristics of nebulized terbutaline sulphate using the next generation impactor (NGI) and CEN method. J Aerosol Med Pulm Drug Del 22(1):19–28. doi:https://doi.org/10.1089/jamp.2008.0650.
   PubMedGoogle Scholar
• Abdou EM, Kandil SM, Miniawy H. (2017). Brain targeting efficiency of antimigraine drug loaded mucoadhesive intranasal nanoemulsion. Int J Pharm 30(529):667–77. doi:https://doi.org/10.1016/j.ijpharm.2017.07.030.
   Google Scholar
• Abdul Motalib MM, Afrina A, Khan SM, et al. (2012). Method validation for the determination of water content of metered dose inhaler by Karl Fischer coulometer. Int Res J Pharm 3:144–7.
   Google Scholar
• Aghdam MH, Ghanbarzadeh S, Javadzadeh Y, Hamishehkar H. (2016). Aggregated nanotransfersomal dry powder inhalation of itraconazole for pulmonary drug delivery. Adv Pharm Bull 6(1):57–64. doi:https://doi.org/10.15171/apb.2016.009.
   PubMedGoogle Scholar
• Ahonen K, Hamalainen ML, Rantala H, Hoppu K. (2004). Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology 62:883–7.
   PubMed Web of Science ®Google Scholar
• Al-Qadi S, Grenha A, Carrion-Recio D, et al. (2012). Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J Control Release 157:383–90. doi:https://doi.org/10.1016/j.jconrel.2011.08.008.
   Google Scholar
• Aurora S, Kori S, Barrodale P, et al. (2007). Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache 47:1443–6. doi:https://doi.org/10.1111/j.1526-4610.2007.00922.x.
   Google Scholar
• Authier S, Accardi MV, Paquette D, et al. (2016). Functional neurotoxicity evaluation of noribogaine using video-EEG in cynomolgus monkeys. J Pharmacol Toxicol Methods 81:306–12. doi:https://doi.org/10.1016/j.vascn.2016.04.012.
   Google Scholar
• Awari VP, Meyyanathan SN, Karthik Y, Venkatesh DN. (2013). Bio analytical HPLC method development and validation of zolmitriptan in rabbit plasma. Int J Bio Pharm Res 4:1160–4.
   Google Scholar
• Bai S, Ahsan F. (2010). Inhalable liposomes of low molecular weight heparin for the treatment of venous thromboembolism. J Pharm Sci 99:4554–64. doi:https://doi.org/10.1002/jps.22160.
   Google Scholar
• Byron PR, Hindle M, Lange CF, et al. (2010). In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols. J Aerosol Med Pulm Drug Deliv 23(2):S59–69. doi:https://doi.org/10.1089/jamp.2010.0846.
   PubMedGoogle Scholar
• Cheng YS, Fu CS, Yazzie D, Zhou Y. (2001). Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica. J Aerosol Med 14(2):255–66. doi:https://doi.org/10.1089/08942680152484180.
   PubMedGoogle Scholar
• Chua AL, Silberstein S. (2016). Inhaled drug therapy development for the treatment of migraine. Expert Opin Pharmacother 17(13):1733–43. doi:https://doi.org/10.1080/14656566.2016.1203901.
   PubMed Web of Science ®Google Scholar
• Cittadini E, May A, Straube A, et al. (2006). Effectiveness of intranasal zolmitriptan in acute cluster headache. Arch. Neurol 63:E1–E6. doi:https://doi.org/10.1001/archneur.63.11.nct60002.
   Google Scholar
• Cortelli P, Allais G, Benedetto C. (2017). Overview of triptans in the treatment of acute migraine. Eur Neurol Rev 12:71–7. doi:https://doi.org/10.17925/ENR.2017.12.02.71.
   Google Scholar
• Egla M, Abd Al hammid SN. (2016). Design of zolmitriptan liquisolid orodispersible tablets and their in vitro evaluation. Int J Pharm Sci 9:297–303.
   Google Scholar
• Gallagher R. (2004). What do patients want from acute migraine treatment? Cephalalgia 24(2):8–15. doi:https://doi.org/10.1111/j.1468-2982.2004.00893.x.
   PubMedGoogle Scholar
• Goadsby PJ, Yates R. (2006). Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy. Headache doi:https://doi.org/10.1111/j.1526-4610.2006.00301.x.
   Google Scholar
• Green MW, Green LM, Rothrock JF. (2005). The Pharmacologic treatment of migraine. In: Managing your headaches. New York: Springer; pp 13–43.
   Google Scholar
• Haddrell AE, Lewis D, Tanya T, et al. (2017). Pulmonary aerosol delivery and the importance of growth dynamics. Ther Deliv 8(12):1051–61. doi:https://doi.org/10.4155/tde-2017-0093.
   Google Scholar
• Hamishehkar H, Emami J, Najafabadi AR, et al. (2010). Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats. Biopharm Drug Dispos 31:189–201. doi:https://doi.org/10.1002/bdd.702.
   Google Scholar
• Hickey AJ. (2002). Delivery of drugs by the pulmonary route. In: Banker GS, Rhodes CT, eds. Modern Pharmaceutics. New York: Marcel Dekker; pp 479–99.
   Google Scholar
• Hickey AJ. (2013). Clinical trials and translational medicine commentaries: back to the future: inhaled drug products. J Pharm Sci.102(4):1165–72. doi:https://doi.org/10.1002/jps.23465
   PubMed Web of Science ®Google Scholar
• Institute of Laboratory Animal Resources (ILAR). (1996) Guide for the Care and Use of Laboratory Animals. NIH Publication No. 85-23 (revised 1996). National Academy Press, Washington, D.C. Available from www.nap.edu/openbook.php?record_id=5140
   Google Scholar
• Khale A, Bajaj A. (2011). Formulation and development of metered dose inhalations of salbutamol in solution form. Indian J Pharm Sci 73(5): 543–49. doi:https://doi.org/10.4103/0250-474X.99008.
   PubMedGoogle Scholar
• Lombry C, Marteleur A, Arras M, et al. (2004). Local and systemic immune responses to intratracheal instillation of antigen and DNA vaccines in mice. Pharm Res 21:127–35.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Marzio LD, Rinaldi F, et al. (2011). Pulmonary delivery: innovative approaches and perspectives. J Biomed Nanobiotechnol 2:567–75. doi:https://doi.org/10.4236/jbnb.2011.225068.
   Google Scholar
• Misra A, Ganesh S, Shahiwala A, Shah SP. (2003). Drug delivery to the central nervous system: a review. J Pharm Pharm Sci 6:252–73.
   PubMed Web of Science ®Google Scholar
• Mittal D, Ali A, Md S, et al. (2014). Insights into direct nose to brain delivery: current status and future perspective. Drug Del 21:75. doi:https://doi.org/10.3109/107144.2013.838713.
   PubMed Web of Science ®Google Scholar
• Murata S, Izumi T, Ito H. (2012). Effect of the moisture content in aerosol on the spray performance of Stmerin® D hydrofluoroalkane preparations (2). Chem Pharm Bull 60: 593–7.
   PubMed Web of Science ®Google Scholar
• Myrdal PB, Sheth P, Stein SW. (2014). Advances in metered dose inhaler technology: formulation development. AAPS Pharm Sci Tech 15(2):434–55. doi:https://doi.org/10.1208/s12249-013-0063-x.
   PubMed Web of Science ®Google Scholar
• Nahar K, Gupta N, Gauvin R, et al. (2013). In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals. Eur J Pharm Sci 49:805–18. doi:https://doi.org/10.1016/j.ejps.2013.06.004.
   Google Scholar
• Newman SP. (2005). Principles of metered-dose inhaler design. Respir Care 50:1177–90.
   PubMedGoogle Scholar
• O'Donnell KP, Williams RO. III (2013). Pulmonary dispersion formulations: the impact of dispersed powder properties on pressurized metered dose inhaler stability. Drug Dev Ind Pharm 39(3):413–24. doi:https://doi.org/10.3109/03639045.2012.664145.
   PubMed Web of Science ®Google Scholar
• Ooi J, Traini D, Boyd BJ, et al. (2015). Determination of physical and chemical stability in pressurised metered dose inhalers: potential new techniques. Expert Opin Drug Deliv 12(10):1–15. doi:https://doi.org/10.1517/17425247.2015.1046834.
   PubMedGoogle Scholar
• Patel B, Gupta V, Ahsan F. (2012). PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin. J Control Release 162:310–20.
   PubMed Web of Science ®Google Scholar
• Patil JS, Sarasija S. (2012). Pulmonary drug delivery strategies: a concise, systematic review. Lung India 29(1):44–9. doi:https://doi.org/10.4103/0970-2113.92361.
   PubMedGoogle Scholar
• Patton JS, Byron PR. (2007). Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 6(1):67–74. doi:https://doi.org/10.1038/nrd2153 [Database].
   PubMed Web of Science ®Google Scholar
• Pilcer G, Amighi K. (2010). Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm 392:1. doi:https://doi.org/10.1016/j.ijpharm.2010.03.017.
   PubMed Web of Science ®Google Scholar
• Pritchard JN. (2001). The influence of lung deposition on clinical response. J Aerosol Med 14(1):S19–26. doi:https://doi.org/10.1089/08942680150506303.
   PubMedGoogle Scholar
• Rabinowitz JD, Lloyd PM, Munzar P, et al. (2006). Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation. J Pharmaceutic Sci 95(11):2438–51. doi: https://doi.org/10.1002/jps.20694
   Google Scholar
• Shi S, Ashley ES, Alexander BD, Hickey AJ. (2009). Initial characterization of micafungin pulmonary delivery via two different nebulizers and multivariate data analysis of aerosol mass distribution profiles. AAPS Pharm Sci Tech 10:129–137. doi:https://doi.org/10.1208/s12249-009-9185-6.
   Google Scholar
• Shrikhandea SS, Raoa A, Ambekara A, Bajajb AN. (2011). Metered dose inhalation formulations of salbutamol sulphate using non-CFC propellant tetrafluoroethane. Int J Pharm Sci Drug Res 3:292–6.
   Google Scholar
• Silberstein S. (2012). MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine. Expert Opin Pharmacother 13(13):1961–8. doi:https://doi.org/10.1517/14656566.2012.711319.
   PubMed Web of Science ®Google Scholar
• Simona A, Amarob MI, Cabrala LM, et al. (2016). Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate. Int J Pharm 501:124–138. doi:https://doi.org/10.1016/j.ijpharm.2016.01.066.
   Google Scholar
• Smyth HD. (2003). The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Adv Drug Deliv Rev 55:807–28.
   PubMed Web of Science ®Google Scholar
• Sorkness RL, Remus JL, Rosenthal LA. (2014). Systemic and pulmonary effects of fluticasone administered through a metered-dose inhaler in rats. J Allergy Clin Immunol 114(5):1027–1032. doi:https://doi.org/10.1016/j.jaci.2004.07.015.
   Google Scholar
• Stank K, Steckel H. (2013). Physico-chemical characterisation of surface modified particles for inhalation. Int J Pharm 448:9–18. doi:https://doi.org/10.1016/j.ijpharm.2013.03.009.
   Google Scholar
• Stein SW, Sheth P, Hodson PD, Myrdal PB. (2014). Advances in metered dose inhaler technology: hardware development. AAPS Pharm Sci Tech 15(2): 326–38. doi:https://doi.org/10.1208/s12249-013-0062-y.
   PubMed Web of Science ®Google Scholar
• Sukasamea N, Boonmea P, Srichanaa T. (2011). Development of budesonide suspensions for use in an HFA pressurized metered dose inhaler. Sci Asia 37:31–7. doi:https://doi.org/10.2306/scienceasia1513-1874.2011.37.031.
   Google Scholar
• Talasila GKM, Mukkala BVP, Vattikuri S. (2013). Formulation and evaluation of CFC free inhalers for beclomethasone dipropionate. Braz J Pharm Sci 49(2):221–31. doi:https://doi.org/10.1590/S1984-82502013000200004.
   Google Scholar
• Thomas C, Rawat A, Bai S, Ahsan F. (2008). Feasibility study of inhaled hepatitis B vaccine formulated with tetradecylmaltoside. J Pharm Sci 97:1213–1223. doi:https://doi.org/10.1002/jps.21069.
   Google Scholar
• Uddin M, Hossain M, Mamun A, et al. (2016). Pharmacopoeial standards and specifications for pharmaceutical aerosols: in-process and finished products quality control tests. Adv Res 6:1. doi:https://doi.org/10.9734/AIR/2016/22442.
   Google Scholar
• USP 29b, (2007)General Chapter <61>, microbiological examination of nonsterile products: microbial enumeration tests.USP31–NF26 29:1714.
   Google Scholar
• USP29a, (2007) 601. Aerosoles, nasal sprays, metered dose inhalers, and dry powder inhalers. USP31–NF26 30:1342.
   Google Scholar
• Vu N, Lou JR, Kupiec TC. (2014). Quality control: microbial limit tests for nonsterile pharmaceuticals, part 2. Int J Pharm Compd 18:305–10.
   PubMedGoogle Scholar
• Vyas T, Babbar AK, Sharma RK, Misra A. (2005). Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting. J Drug Targ 13(3):317–24. doi:https://doi.org/10.1080/10611860500246217.
   PubMedGoogle Scholar
• Weers JG. (2000). Dispersible powders for inhalation applications. Innov Pharm Tech 1:111–6.
   Google Scholar
• Williams R, Hu C. (2000a). Investigation of moisture scavengers in pressurized metered-dose inhalers. STP Pharm Sci 10:243–50.
   Google Scholar
• Williams R, Hu C. (2000b). Moisture uptake and its influence on pressurized metereddose inhalers. Pharm Dev Technol 5(2):153–62. doi:https://doi.org/10.1081/PDT-100100530.
   PubMed Web of Science ®Google Scholar
• Yang T, Hussain A, Bai S, et al. (2006). Positively charged polyethylenimines enhance nasal absorption of the negatively charged drug, low molecular weight heparin. J Control Release 115:289–29. doi:https://doi.org/10.1016/j.jconrel.2006.08.015.
   Google Scholar
• Yazdani A, Normandie M, Yousefi M, et al. (2014). Transport and deposition of pharmaceutical particles in three commercial spacer-mdi combinations. Comput Biol Med 54:145–55. doi:https://doi.org/10.1016/j.compbiomed.2014.08.001.
   Google Scholar
• Zhao YZ, Li X, Lu CT, et al. (2012). Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy. Acta Diabetol 49:315–325. doi:https://doi.org/10.1007/s00592-011-0356-z.
   Google Scholar
• Zhu B, Traini D, Young P. (2014). Aerosol particle generation from solution-based pressurized metered dose inhalers: a technical overview of parameters that influence respiratory deposition. Pharm Dev Technol 20(8):879–910. doi:https://doi.org/10.3109/10837450.2014.959176.
   Google Scholar